Trial intelligence / Profile preview

Concerta in the Treatment of Adult ADHD

NCT02215538Phase 3Completed

Sponsor
University of Utah
Start
Nov 2004
Primary completion
Feb 2006
Modality
Small Molecules
Countries
1
01

Overview

A Phase 3 trial of methylphenidate in attention deficit hyperactivity disorder (ADHD), sponsored by University of Utah. Started Nov 2004; status: completed.

02

Drugs

methylphenidate
03

Conditions

attention deficit hyperactivity disorder (ADHD)

Beyond the preview

Go deeper on NCT02215538.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02215538.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call